Hyperinsulinemia and triglyceride-rich lipoproteins

被引:43
作者
Steiner, G
Lewis, GF
机构
[1] TORONTO HOSP,WHO,COLLABORATING CTR STUDY ATHEROSCLEROSIS DIABET,TORONTO,ON M5G 2C4,CANADA
[2] UNIV TORONTO,TORONTO,ON,CANADA
关键词
D O I
10.2337/diab.45.3.S24
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypertriglyceridemia is the most frequent form of hyperlipidemia seen in diabetes, Because hypertriglyceridemia and hyperinsulinemia often coexist in the general population and because patients with NIDDM generally are hyperinsulinemic, me have undertaken a series of in vivo studies to examine the effects of hyperinsulinemia on VLDL production, These studies showed that chronic hyperinsulinemia is accompanied by increased VLDL production and that this occurs even when plasma free fatty acid (FFA) levels have fallen, By contrast, acute hyperinsulinemia is accompanied by a reduction in VLDL production, and this reduction is, at least in part, mediated by an associated reduction in the availability of plasma FFAs as a substrate for VLDL-triglyceride (TG), The studies also raise the possibility that the difference in the dependence of VI;DL production on plasma FFAs in acute versus chronic hyperinsulinemia results from an increase in hepatic lipogenic enzymes and from the availability of an alternate substrate such as fructose, The overall effect of hyperinsulinemia on VLDL production is postulated to reflect both the effect of insulin on apolipoprotein B production and the hepatic synthesis of TG from either plasma FFAs or newly made fatty acids.
引用
收藏
页码:S24 / S26
页数:3
相关论文
共 29 条
  • [1] EFFECT OF A SINGLE INSULIN ADMINISTRATION ON HEPATIC RELEASE OF TRIGLYCERIDES INTO PLASMA
    ALCINDOR, LG
    INFANTE, R
    SOLERARG.C
    POLONOVSKI, J
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1973, 306 (03) : 347 - 352
  • [2] PLASMA-LIPIDS AND DIABETES-MELLITUS IN AN ADULT COMMUNITY
    BARRETTCONNOR, E
    GRUNDY, SM
    HOLDBROOK, MJ
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1982, 115 (05) : 657 - 663
  • [4] FAILURE OF CHRONIC HYPERINSULINEMIA TO SUPPRESS PANCREATIC GLUCAGON INVIVO IN THE RAT
    BRUBAKER, PL
    KAZUMI, T
    HIRANO, T
    VRANIC, M
    STEINER, G
    [J]. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1991, 69 (03) : 437 - 443
  • [5] CATTRAN DC, 1979, ANN INTERN MED, V91, P554, DOI 10.7326/0003-4819-91-4-554
  • [6] DEFECTIVE TRIGLYCERIDE REMOVAL IN LIPEMIA ASSOCIATED WITH PERITONEAL-DIALYSIS AND HEMODIALYSIS
    CATTRAN, DC
    FENTON, SSA
    WILSON, DR
    STEINER, G
    [J]. ANNALS OF INTERNAL MEDICINE, 1976, 85 (01) : 29 - 33
  • [7] DASHTI N, 1987, J LIPID RES, V28, P423
  • [8] PATHOGENESIS OF NIDDM - A BALANCED OVERVIEW
    DEFRONZO, RA
    BONADONNA, RC
    FERRANNINI, E
    [J]. DIABETES CARE, 1992, 15 (03) : 318 - 368
  • [9] EFFECTS OF INSULIN AND GLUCOSE ON VERY LOW-DENSITY LIPOPROTEIN TRIGLYCERIDE SECRETION BY CULTURED RAT HEPATOCYTES
    DURRINGTON, PN
    NEWTON, RS
    WEINSTEIN, DB
    STEINBERG, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1982, 70 (01) : 63 - 73
  • [10] EISENBERG S, 1991, PRIMARY HYPERLIPOPRO, P23